ArticlePhotodiagnosis and photodynamic therapy2018

Combined CB2 receptor agonist and photodynamic therapy synergistically inhibit tumor growth in triple negative breast cancer.

Jiliang Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.